Readers discuss an essay about whether it is a disease and how it should be diagnosed. Also: Fear in schools; natural ...

In this detailed exploration, we will delve into a comparative analysis of two such supplements that have been gathering ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Acadia Pharmaceuticals Inc. today announced that on September 23, 2024, the Board of Directors granted Catherine Owen Adams, Acadia's new Chief Executive Officer, a one-time sign-on equity award of (i ...

Cobenfy targets cholinergic receptors instead of the dopamine receptors long addressed in current schizophrenia drugs — a new treatment approach to the disease.

The best way to experience the third age is to joyfully accept its arrival and indulge in all the magical experiences it has ...

When valuations across the stock markets are high, one should look for sectors with macro tailwinds. Sectors and stocks with ...

Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

The Arkansas Integrative Metabolic Research Center (AIMRC) will host Dr. Danielle Schmitt, assistant professor of biochemistry at the University of California, Los Angeles on Wednesday, Oct. 2.

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

We are excited to welcome these extraordinary and prestigious scientific leaders to the Biomea Scientific Advisory Board,” said Thomas Butler, CEO and Chairman of Biomea. “Each of these visionaries ...